Patients in developing countries who will soon need new treatment regimens for HIV/AIDS will be even more unlikely to receive them, now that international donors are walking away from their funding promises.
Part Three of a three-part series on the consequences of international donors' retreat from funding HIV/AIDS treatment in developing countries.
Sending a message: Patients who have built up resistance to their first treatment regimen urgently need second- or third-line treatment. In many developing countries these drugs are already priced out of reach; funding cuts will only make them less accessible. What message is the international community sending to those who were promised life-long treatment?
